指样突起与蛛网膜下腔出血诊断脑淀粉样血管病的病理验证准确性
本研究为回顾性多中心研究,纳入66例不明原因脑叶出血患者,以神经病理为参考评估急性期CT/MRI上指样突起(FLP)和蛛网膜下腔出血(SAH)对脑淀粉样血管病(CAA)的诊断价值。FLP敏感度0.58、特异度0.74;SAH敏感度0.92、特异度0.43;二者合并敏感度0.79、特异度0.54。
要点
- 在非尸检脑叶出血患者中,FLP对CAA诊断敏感度0.58、特异度0.74。
- SAH对CAA诊断敏感度高(0.92),阴性预测值0.80,但特异度中等(0.43)。
- FLP与SAH合并诊断CAA敏感度0.79、特异度0.54。
核心结论
- 在非尸检患者中,FLP和SAH对CAA的诊断性能低于既往在严重血肿导致早期死亡患者中的报道,但SAH的高敏感度提示其缺失时可能有助于排除CAA。
研究设计与样本
- 回顾性(2002-2022)多中心研究,纳入66例年龄≥45岁、不明原因脑叶出血且具备急性期CT或MRI及神经病理样本的患者。
- 影像和神经病理数据(含Aβ免疫组化)由2名评估者集中共识判读,分析限于含至少10条血管的样本,以神经病理CAA/无CAA为参考标准。
主要发现
- 66例患者来自6个法国中心,年龄65±9岁,男性33%,血肿体积45±26 mL,1年内死亡14%。
- 神经病理样本来自血肿清除48例和活检18例;CAA存在38例(58%),FLP存在29例(44%),SAH存在50例(76%)。
- FLP诊断CAA的敏感度0.58(95%CI 0.41-0.74)、特异度0.74(95%CI 0.54-0.89)。
- SAH诊断CAA的敏感度0.92(95%CI 0.78-0.98)、阴性预测值0.80(95%CI 0.52-0.96)、特异度0.43(95%CI 0.24-0.63)。
- FLP与SAH合并诊断CAA的敏感度0.79(95%CI 0.59-0.92)、特异度0.54(95%CI 0.37-0.71)。
临床怎么用
- 在非尸检脑叶出血患者中,SAH缺失时阴性预测值0.80,可能有助于排除CAA;FLP和SAH合并存在时特异度0.54。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diagnosing cerebral amyloid angiopathy (CAA) after spontaneous lobar intracerebral hemorrhage has significant clinical implications. A previous postmortem study found that the presence of both subarachnoid hemorrhage (SAH) and hematoma finger-like projections (FLP) on acute-stage computed tomography strongly rules in CAA. In the present study, we assessed the diagnostic value of these imaging markers against histopathologic diagnosis in less severe presentations. METHODS: This retrospective (2002-2022) multicenter study included patients aged ≥45 years with lobar intracerebral hemorrhage of unknown cause, for whom acute-stage computed tomography or magnetic resonance imaging and neuropathological samples from hematoma evacuation or biopsy were available. Centralized consensus reading (2 raters) of imaging and neuropathological data (including Aβ immunohistochemistry) were performed. Analysis was restricted to samples containing at least 10 vessels. The diagnostic performance was evaluated against the neuropathological reference, that is, CAA/no CAA. RESULTS: We analyzed data from 66 patients (age, 65±9 years; men, 33%; hematoma volume, 45±26 mL; death within 1 year, 14%) from 6 French centers. Neuropathological material included samples from hematoma evacuation (n=48) and biopsy (n=18). CAA was present in 38 (58%) patients, and FLP and SAH were observed in 29 (44%) and 50 (76%) patients, respectively. FLP had a sensitivity of 0.58 (95% CI, 0.41-0.74) and a specificity of 0.74 (95% CI, 0.54-0.89) for the diagnosis of CAA. SAH demonstrated a high sensitivity of 0.92 (95% CI, 0.78-0.98; negative predictive value=0.80 [0.52-0.96]) but moderate specificity of 0.43 (95% CI, 0.24-0.63). The combined presence of FLP and SAH had a specificity of 0.54 (95% CI, 0.37-0.71) and a sensitivity of 0.79 (95% CI, 0.59-0.92). CONCLUSIONS: This study is the first to evaluate the diagnostic performance of FLP and SAH with histopathologic reference in nonautopsied patients. The results suggest these markers have lower diagnostic performance than previously reported in severe hematomas leading to early death. However, the high sensitivity of SAH suggests its potential clinical utility in ruling out CAA when absent.
引用
- Maury A, Benzakoun J, Bani-Sadr A, et al. Diagnostic Accuracy of Finger-Like Projections and Subarachnoid Hemorrhage for Cerebral Amyloid Angiopathy: Pathological Validation From Lobar Hematoma Evacuation or Brain Biopsy. Stroke. 2025. PMID: 40270245. doi:10.1161/STROKEAHA.124.050159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。